Michal Schäfer1,2, Stephen Humphries3, Kurt R Stenmark4, Vitaly O Kheyfets1,2, J Kern Buckner1, Kendall S Hunter1,2, Brett E Fenster1. 1. Department of Cardiology, National Jewish Health, 1400 Jackson St, Denver, CO 80206, USA. 2. Department of Bioengineering, University of Colorado Denver, Anschutz Medical Campus, Research 2 - Building P15, 12700 E 19th Avenue, Aurora, CO 80045-2560, USA. 3. Department of Radiology, National Jewish Health, 1400 Jackson St, Denver, CO 80206, USA. 4. Division of Pediatrics, Department of Critical Care, University of Colorado, Anschutz Medical Campus, 212700 E. 19th Avenue, Box B131, Aurora, CO 80045, USA.
Abstract
Aims: To investigate the possibility that vorticity assessed by four-dimensional flow cardiac magnetic resonance (4D-Flow CMR) in the left ventricle of patients with mild-to-moderate chronic obstructive pulmonary disease (COPD) is a potential marker of early LV diastolic dysfunction (LVDD) and more sensitive than standard echocardiography, and whether changes in vorticity are associated with quantitative computed tomography (CT) and clinical markers of COPD, and right ventricular (RV) echocardiographic markers indicative of ventricular interdependency. Methods and results: Sixteen COPD patients with presumptive LVDD and 10 controls underwent same-day 4D-Flow CMR and Doppler echocardiography to quantify early and late diastolic vorticity as well as standard evaluation for LVDD. Furthermore, all patients underwent detailed CT analysis for COPD markers including percent emphysema and air trapping. The 4D-Flow CMR derived diastolic vorticity measures were correlated with CT measures, standard clinical and CMR markers, and echocardiographic diastolic RV metrics. Early diastolic vorticity was significantly reduced in COPD patients (P < 0.0001) with normal left ventricular (LV) mass, geometry, systolic function, and no or mild signs of Doppler LVDD when compared with controls. Vorticity significantly differentiated COPD patients without echocardiographic signs of LVDD (n = 11) from controls (P < 0.0001), and from COPD patients with stage I LVDD (n = 5) (P < 0.0180). Vorticity markers significantly correlated with CT computed measures, CMR-derived RV ejection fraction, echocardiographic RV diastolic metrics, and 6-minute walk test. Conclusion: 4D-Flow CMR derived diastolic vorticity is reduced in patients with mild-to-moderate COPD and no or mild signs of LVDD, implying early perturbations in the LV flow domain preceding more obvious mechanical changes (i.e. stiffening and dilation). Furthermore, reduced LV vorticity appears to be driven by COPD induced changes in lung tissue and parallel RV dysfunction.
Aims: To investigate the possibility that vorticity assessed by four-dimensional flow cardiac magnetic resonance (4D-Flow CMR) in the left ventricle of patients with mild-to-moderate chronic obstructive pulmonary disease (COPD) is a potential marker of early LV diastolic dysfunction (LVDD) and more sensitive than standard echocardiography, and whether changes in vorticity are associated with quantitative computed tomography (CT) and clinical markers of COPD, and right ventricular (RV) echocardiographic markers indicative of ventricular interdependency. Methods and results: Sixteen COPDpatients with presumptive LVDD and 10 controls underwent same-day 4D-Flow CMR and Doppler echocardiography to quantify early and late diastolic vorticity as well as standard evaluation for LVDD. Furthermore, all patients underwent detailed CT analysis for COPD markers including percent emphysema and air trapping. The 4D-Flow CMR derived diastolic vorticity measures were correlated with CT measures, standard clinical and CMR markers, and echocardiographic diastolic RV metrics. Early diastolic vorticity was significantly reduced in COPDpatients (P < 0.0001) with normal left ventricular (LV) mass, geometry, systolic function, and no or mild signs of Doppler LVDD when compared with controls. Vorticity significantly differentiated COPDpatients without echocardiographic signs of LVDD (n = 11) from controls (P < 0.0001), and from COPDpatients with stage I LVDD (n = 5) (P < 0.0180). Vorticity markers significantly correlated with CT computed measures, CMR-derived RV ejection fraction, echocardiographic RV diastolic metrics, and 6-minute walk test. Conclusion: 4D-Flow CMR derived diastolic vorticity is reduced in patients with mild-to-moderate COPD and no or mild signs of LVDD, implying early perturbations in the LV flow domain preceding more obvious mechanical changes (i.e. stiffening and dilation). Furthermore, reduced LV vorticity appears to be driven by COPD induced changes in lung tissue and parallel RV dysfunction.
Authors: Andrea Rossi; Zaurbek Aisanov; Sergey Avdeev; Giuseppe Di Maria; Claudio F Donner; José Luis Izquierdo; Nicolas Roche; Thomas Similowski; Henrik Watz; Heinrich Worth; Marc Miravitlles Journal: Respir Med Date: 2015-04-03 Impact factor: 3.415
Authors: Steven M Kawut; Hooman D Poor; Megha A Parikh; Katja Hueper; Benjamin M Smith; David A Bluemke; João A C Lima; Martin R Prince; Eric A Hoffman; John H M Austin; Jens Vogel-Claussen; R Graham Barr Journal: J Am Coll Cardiol Date: 2014-11-03 Impact factor: 24.094
Authors: Frank A Flachskampf; Tor Biering-Sørensen; Scott D Solomon; Olov Duvernoy; Tomas Bjerner; Otto A Smiseth Journal: JACC Cardiovasc Imaging Date: 2015-09
Authors: Michal Schäfer; Alex J Barker; Gareth J Morgan; James Jaggers; Matthew L Stone; Lorna P Browne; D Dunbar Ivy; Max B Mitchell Journal: Int J Cardiovasc Imaging Date: 2020-01-06 Impact factor: 2.357
Authors: David R Rutkowski; Gregory P Barton; Christopher J François; Niti Aggarwal; Alejandro Roldán-Alzate Journal: Radiol Cardiothorac Imaging Date: 2020-02-27
Authors: Michal Schäfer; Alex J Barker; Vitaly Kheyfets; Kurt R Stenmark; James Crapo; Michael E Yeager; Uyen Truong; J Kern Buckner; Brett E Fenster; Kendall S Hunter Journal: J Am Heart Assoc Date: 2017-12-20 Impact factor: 5.501
Authors: Corina Kräuter; Ursula Reiter; Clemens Reiter; Volha Nizhnikava; Marc Masana; Albrecht Schmidt; Michael Fuchsjäger; Rudolf Stollberger; Gert Reiter Journal: Magn Reson Med Date: 2020-06-18 Impact factor: 4.668